text:
Please enter the email address associated with your account and we will send you a link to reset your password.
Your password reset link is on its way. If you have problems accessing your account, please contact us at 888-757-4774 and we'll help you out.
I'm sorry, your email address was not found in our system.
If you think this is a mistake, please contact Customer Service at 888-757-4774 or email us.
Location: 185 Price Parkway, Farmingdale, NY 11735
Hours: 8:00AM - 7:00PM, Mon - Fri.SPECIAL HOURS: We will be closed on Memorial Day 5/25.
This product does not comply with the "Safe Drinking Water Act,"
which requires that products used in any system providing water for human
consumption (drinking or cooking) to meet low-lead standards.
Please check the box below to confirm you are aware of that this item is for non-potable water applications only.
This product will NOT be used in the installation or repair of a potable water (human consumption) application.
You must agree to this statement in order to purchase this product.
Do not use this item for any installation or repair of potable water applications.
This product does not comply with the "Safe Drinking Water Act,"
which requires that products meet low-lead standards in order to be used in systems providing water for human consumption (drinking or cooking).
This item is for non-potable (non-human consumption) water applications only.
Brand: Cello
We accept returns of any unused and unopened merchandise within 5 days of receipt and accept returns of defective merchandise within 14 days of receipt. All returns must be accompanied by a Return Goods Authorization, which may be obtained by contacting a customer service representative either by phone or by e-mail. All manufacturer warranties are honored and claims should be made through SupplyHouse.com.
See full Return Policy.
Add this item to your cart to calculate shipping cost.
The entire staff at SupplyHouse is committed to doing everything we can to ship your order out accurately and as quickly as possible. Most orders ship within 24-48 hours and expedited orders go out the same day when placed before 3:00pm EST. If an item is back ordered for any reason, you will be notified via e-mail. Please note in the special instructions at checkout if you need receive your order by a specific date.
See full Shipping Policy.
SupplyHouse.com is committed to providing you with the highest quality products at the lowest prices available. We are committed to competitive prices and will honor our Low Price Guarantee if you find an identical item at a lower price.
For complete information on our low price guarantee, go here.
There is a Minimum Advertised Price (MAP) allowed by the manufacturer on this product. Add item to cart for lowest price.
We are dedicated to protecting your order information. Because of this, all personal data that is transmitted through our site is encrypted using SSL or "Secure Socket Layer" technology which encrypts your order information to avoid the decoding of your information by anyone other than SupplyHouse.
At SupplyHouse.com, we are committed to protecting your privacy. This means that we will not distribute, sell or rent your name or personal information about you to any third party without your permission.
For complete safe shopping information, go here.
Your privacy is of great concern to SupplyHouse. We use the information you provide to process your order and to ensure that your experience on our site is as enjoyable and efficient as possible. Our primary focus and greatest concern is you, our customer. We respect your privacy and therefore do not sell, rent or loan any of your personal information to any third party.
We are committed to protecting your privacy. We use the information that we collect about you to process your orders and to provide a personalized shopping environment. When you purchase products from SupplyHouse.com or register for any SupplyHouse.com services, we automatically place you on our list to receive e-mail updates about special offers, new products, and new services.
For our complete privacy policy information, go here.
A credit card Identification Number is an added safeguard for your credit card purchases. Depending on the type of credit card you use, it is the 3- or 4-digit number printed on the back or front of your credit card. For most online credit card purchases from us, the Identification Number is required information.
MasterCard: Your identification number is the 3-digit number found on the back of your credit card near the signature panel.
Visa: Your identification number is the 3-digit number found on the back of your credit card near the signature panel.
American Express: Your identification number is the 4-digit number found on the far right on the front of your credit card.
Copper Long Turn Elbow
(based on 11 reviews)
Ratings Distribution
5 Stars
4 Stars
3 Stars
2 Stars
1 Stars
of respondents would recommend this to a friend.
Reviewed by 11 customers
Sort by
Displaying reviews 1-10
Back to top
Previous | Next »
Good price on a hard to find item
By Schweity
from Brooklyn, NY
Comments about 3/8" Copper 90° Long Turn Elbow:
I have a hard time finding 3/8" fittings, as well as long-radius elbows. The parts are otherwise identical to larger-size fittings. Highly recommended for getting hot water to lavatories and other low-flow fixtures more quickly.
Bottom Line Yes, I would recommend this to a friend
Was this review helpful? Yes / No
- You may also flag this review
1/2" CxC long radius 90* elbow.
By Tom H.
from Springfield, Il.
Comments about 1/2" CxC 90° Long Turn Elbow:
I use these instead of a short turn 90* elbow. I get a little better water pressure and volume.
Excellent product
By Big John
from Rogers, Mn.
Comments about 3/4" CxC 90° Long Turn Elbow:
Quick and prompt service. They had the part that I was looking for.
Excellent Service
By jwmachshop
from Washington, IL
Comments about 5/16"" OD Copper 90° Long Turn Elbow:
Great for model engineering projects
Best Price I could find
By Gary
from Ventura, Ca.
Comments about 1-1/2" CxC 90° Long Turn Elbow:
I thought they made a mistake on the price of this copper fitting,but after recieving the order I will be ordering more from PEX.
Perfect shape for my application
By Ed
from Amherst, NH
The long turn feature of this fitting gives my final product a sleek look. This style fitting is not available at local suppliers and has a much higher cost when ordered through them. I wish the hubs had a tighter fit, however.
Prompt Delivery of Unusual Item
By Handyman Don
from Detroit, Michigan
Comments about 1-1/4" CxC 90° Long Turn Elbow:
I needed a long radius elbow for a special project I was working on. Even large pipe warehouses in the major city where I live did not have it in stock because it is an item that is rarely used. Pex Products had it, and a variety of others like it, and I was able to find it easily on their website. It was shipped promptly and arrived packaged very well. I would recommend the company.
Good customer service
Fitting is used in an automotive application. The part is unique to the application as it has a gradual curve. I wish it were available in a lighter less costly material.
very good product for long 90 elbow
By Dave
from KC MO
very good product for high calcium content and hard water. short elbows experience fast build up and calcification.
A great price [...]
from Santa Fe NM
Perfect for not constricting the flow like a regular 90 elbow would.
Do you have questions about this product?
get answers from real customers and in-house experts with AnswerBox.
Know the answer? Answer this question
8 answers
Do you have a question about this product?
Page 0 of 7
Subscribe to our Channel
Like Us on Facebook
Visit Our Blog
At SupplyHouse.com, our goal is to bring you the highest quality plumbing, heating and HVAC supplies at competitive prices. Our product catalog includes PEX Plumbing Supplies, Radiant Heat Supplies, VisionPro Honeywell Thermostats, Taco pumps and mini-split air conditioners. If there are items you are looking for but can't find on our website, please contact our Customer Service Representatives & we will do our best to find what you need.
© 2015 SupplyHouse.com


text:
First, let me be clear about this. While those sandy marks on either of Claudia Romani's blessed cheeks do clearly resemble my little eager baby hands, I am nowhere near Miami Beach at the moment. As always, my alibi continues to be drunk and passed out in a strip club in Los Angeles where several girls named Savannah can vouch for my all night stay. Still, I wish those were the mark of my prurient paws for the mere touch of Claudia's booty is said to have the healing powers of the Fountain of Youth. Or at least two aspirin and a Viagra. Hot damn her blessed bottom makes me want to do extraordinarily stupid things.
As you know, once the laws of this land catch up to my internal moral compass, I shall take Claudia's killer tush and make it my bride. If a man can't love another woman's asstastic forever and ever, I don't know what love is. Truly I don't. My family already knows. But I want the entire world to know. I love Claudia Romani's butt! That was my Lloyd Dobler moment. Enjoy.

subset: commoncrawl


text:
Hotel Hostellerie La Bergerie du Cap - Le Cap-d'Agde
4 Avenue de Cassiopee Cap d'Agde - Le Cap-d'Agde1-877-662-6988
Located in a peaceful residential area, yet not far from the city center and marina of Le Cap d'Agde, this charming 3-star hotel provides the perfect spot to combine leisure and relaxation on the shores of the Mediterranean Sea. Within walking distance of sandy beaches, the smoke-free La Bergerie du Cap features a sparkling outdoor swimming pool and hot tub as well as a beautiful terrace, offering guests a truly relaxing atmosphere.
With a snack bar, secure outdoor parking (for a fee), complimentary wireless Internet access, a computer station, secretarial services, luggage storage, and complimentary newspapers in the lobby, Hotel La Bergerie du Cap is the ideal destination for a pleasant holiday in sunny southern France. The hotel offers in-room accessibility and accessible bathrooms.
These reviews have been left by customers who actually stayed at this hotel
Check Availability at Hotel Hostellerie La Bergerie du Cap
Breakfast at Hotel Hostellerie La Bergerie du Cap
A buffet breakfast is served between 8:30 AM and 12:30 PM for a fee.
Hotel Facilities at Hostellerie La Bergerie du Cap
- Luggage room
- Multilingual staff
- Newspapers
- City tour
- Front desk - 24 hour
- Pool bar
- Entire property is non-smoking
- Room service - limited hour
- Pets accepted
- Internet/Email services
- Outdoor swimming pool
- Hydromassage Jacuzzi
- Private parking
Know before you go
Check-in: between 3 PM and 11 PM.
Check-out: before noon.
Guests planning to arrive after 11 PM must contact this property in advance to arrange check-in. Please contact the office using the information on the reservation confirmation received after booking.
PolicyExtra-person charges may apply and vary depending on hotel policy.
Government-issued photo identification and a credit card or cash deposit are required at check-in for incidental charges.
Special requests are subject to availability upon check-in and may incur additional charges. Special requests cannot be guaranteed.
City tax and/or any other fees charged by the hotel
The following fees and deposits are charged by the property at time of service, check-in, or check-out.
- Fee for buffet breakfast: EUR 16 per person (approximately)
- Self parking fee: EUR 13 per day
- Pet fee: EUR 12 per pet, per day
- Rollaway bed fee: EUR 30 per night
The above list may not be comprehensive. Fees and deposits may not include tax and are subject to change.
You'll be asked to pay the following charges at the hotel:
- A tax is imposed by the city: EUR 1.65 per person, per night
We have included all charges provided to us by the property. However, charges can vary, for example, based on length of stay or the room you book.
National ratingThis hotel has received its official star rating from the French Tourism Development Agency, ATOUT France.
Hostellerie La Bergerie du Cap Hotel reviews
- May 2012
- Venere Guest
- Couple
- France
- May 2010
- Venere Guest
- Couple
- France
Loading reviews in other languages...
- August 2012
- Venere Guest
- Couple
- Germany
Hostellerie La Bergerie du Cap Hotel reviews by TripAdvisor
Room Details
Book your pet-friendly accommodation at Hostellerie La Bergerie du Cap, offering 12 guest rooms with climate control. Satellite TV channels offer entertainment at the end of a busy day. Business travelers visiting the Cap d'Agde area will have access to free wireless high-speed Internet access as well as desks and safes.
Minibars and hair dryers are supplied in each room to facilitate basic travel needs. Rooms also include soundproofing and air conditioning.
Accommodation Services
- Air conditioning
- Mini bar
- Soundproof rooms
- Hairdryer in each room
- Safe
- Satellite TV
- Desk
- Individually controlled air conditioning
- Wireless Internet access
How to reach Hostellerie La Bergerie du Cap HotelBy car
From the A9 highway exit at Agde Bessan and head towards Cap d'Agde. Once in Cap d'Agde take the direction of Maraval/Naturisme and at the 1st roundabout follow the hotel signs.
Distances from Hotel Hostellerie La Bergerie du CapMusee de l'Ephebe - 1.2 km / 0.7 mi
Captain Jacko - 1.5 km / 0.9 mi
Cap d'Agde Golf Club - 2.1 km / 1.3 mi
Cap d'Agde Beach - 2.4 km / 1.5 mi
Rochelongue Beach - 3.3 km / 2.1 mi
Fort de Brescou - 3.8 km / 2.4 mi
Agde Cathedral - 4.2 km / 2.6 mi
Noilly Prat Cellars - 6.5 km / 4 mi
Domaine Saint Hilaire Winery - 16.5 km / 10.3 mi
Saint-Thomas Golf Club - 16.8 km / 10.5 mi
Sete Casino - 17.1 km / 10.6 mi
Espace Georges Brassens - 17.2 km / 10.7 mi
Loupian Villa Museum - 17.9 km / 11.1 mi
Theatre of the Sea - 18 km / 11.2 mi
Museum of the Sea - 18 km / 11.2 mi
The preferred airport for Hostellerie La Bergerie du Cap is Beziers (BZR-Cap d'Agde) - 13.3 km / 8.3 mi.
Distances are calculated in a straight line from the property's location to the point of interest or airport and may not reflect actual travel distance.
Distances are displayed to the nearest 0.1 km and mile.
Transportation services Hotel Hostellerie La Bergerie du Cap
- Private parking
We have the accommodation you need, all over the world
- • Renaissance St. Petersburg Baltic Hotel - St Petersburg, Russia
- • Hotel Restaurant Baron - Tiranë, Albania
- • B&B Santa Maria del Buon Consiglio - Bari, Italy
- • Reina Roja Hotel - Playa del Carmen, Mexico
- • Hotel De Vere Venues Harben House - Newport Pagnell, United Kingdom
- • Hotel Jurnieks - Riga, Latvia
- • Hotel La Clé des Champs - Claix, France
- • Inn Mexico P R - Santiago de Compostela, Spain
- • Australian Heritage Hotel - Sydney, Australia
- • Catalonia Catedral Hotel - Barcelona, Spain
- • Hotel Marina Bay - Rimini, Italy
- • Hampton Inn & Suites Las Cruces I-25 - Las Cruces, USA
- • Four Seasons Resort Whistler - Whistler, Canada
- • Bewleys Hotel Dublin Airport - Dublin, Ireland
- • Hotel Palazzo Lovera - Cuneo, Italy
- • Kumluca Hotels, Turkey
- • Kochi Hotels, India
- • Dubrovnik Hotels, Croatia
- • Augustów Hotels, Poland
- • Dubrovnik Hotels, Croatia
- • Peso da Régua Hotels, Portugal
- • Valea Doftanei Hotels, Romania
- • Lamoura Hotels, France
- • Wellin Hotels, Belgium
- • Wadduwa Hotels, Sri Lanka
- • Cow Bay Hotels, Australia
- • Dubrovnik Hotels, Croatia
- • Davos Wiesen Hotels, Switzerland
- • Aversa Hotels, Italy
- • Ravna Gora Hotels, Croatia


text:
Comfort Inn Near Greenfield Village - Dearborn, Detroit
20061 Michigan Avenue - Detroit1-877-662-6988
Free breakfast is just one of the great things you'll find at Comfort Inn Near Greenfield Village, a formidable choice for guests looking for family-friendly Dearborn hotels.
This Dearborn hotel offers an indoor pool and laundry facilities. You can find a fitness center on site so you will be able to take some time out to de-stress. Staff can provide express check-out.
The lobby offers a TV, free newspapers and a safe deposit box at the front desk. Free Wi-Fi is provided. Planning a meeting? This hotel has a meeting room, as well as a 24-hour business center. Other amenities include an area shuttle.
We show TripAdvisor reviews for new Venere hotels that haven't been reviewed yet
Check Availability at Comfort Inn Near Greenfield Village
Breakfast at Comfort Inn Near Greenfield Village
A free buffet breakfast is available between 6 AM and 10 AM.
Facilities at Comfort Inn Near Greenfield Village
- Gym
- Indoor swimming pool
- Meeting Room
- Business Center
- Entire property is non-smoking
- Laundry room
- Newspapers
- Front desk - safety deposit box
- Internet/Email services
- TV Lounge
- Shuttle service
- Free parking
Know before you go
- The property has connecting/adjoining rooms, which are subject to availability and can be requested by contacting the property using the number on the booking confirmation.
Check-in: after 3 PM.
Check-out: before noon.
PolicyExtra-person charges may apply and vary depending on hotel policy.
Government-issued photo identification and a credit card or cash deposit are required at check-in for incidental charges.
Special requests are subject to availability upon check-in and may incur additional charges. Special requests cannot be guaranteed.
City tax and/or any other fees charged by the hotel
The following fees and deposits are charged by the property at time of service, check-in, or check-out.
- Crib (infant bed) fee: USD 10 per night
- Rollaway bed fee: USD 10 per night
The above list may not be comprehensive. Fees and deposits may not include tax and are subject to change.
Comfort Inn Near Greenfield Village is also known as
Comfort Inn at Greenfield Village
Comfort Inn At Greenfield Village Hotel
Comfort Inn At Greenfield Village Hotel Dearborn
Hampton Inn Dearborn
Dearborn Hampton Inn
Room Details
Book your family-friendly accommodation at Comfort Inn Near Greenfield Village, offering 116 guest rooms with video-game consoles and free local calls. Kitchen amenities include refrigerators and microwaves, making it possible to dine in while you travel.
Guests can kick back at the end of a busy day and enjoy plasma televisions with satellite channels and pay movies. Corporate travelers visiting the Dearborn area will benefit from free wireless high-speed Internet access as well as desks. Additional guest comforts include air conditioning and coffee/tea makers.
Bathrooms are outfitted with hair dryers.
Accommodation Services
- Air conditioning
- Pay-Per-View
- Mini fridge
- Extra beds
- Baby cots/cribs available
- Coffee and tea maker
- Hairdryer in each room
- In-room ironing facilities
- Satellite TV
- Desk
- Wireless Internet access
Distances from Comfort Inn Near Greenfield VillageGreenfield Village - 0.5 km / 0.3 mi
Henry Ford Museum - 0.5 km / 0.3 mi
Ford Rouge Factory Tour - 0.7 km / 0.4 mi
Automotive Hall of Fame - 0.8 km / 0.5 mi
University of Michigan Dearborn - 1.3 km / 0.8 mi
Henry Ford Community College - 1.9 km / 1.2 mi
Ford World Headquarters - 2 km / 1.2 mi
Fairlane Town Center Shopping - 4.7 km / 2.9 mi
St Francis d'Assisi Church - 9.9 km / 6.1 mi
Heritage Park - 10 km / 6.2 mi
Historic Fort Wayne - 11 km / 6.8 mi
Gateway Golf Club - 11.6 km / 7.2 mi
Gospel Music Hall of Fame and Museum - 12 km / 7.5 mi
Redford Theatre - 12.3 km / 7.7 mi
Southland Center - 12.3 km / 7.7 mi
The preferred airport for Comfort Inn Near Greenfield Village is Detroit, MI (DTW-Detroit Metropolitan Wayne County) - 13.6 km / 8.4 mi.
Distances are calculated in a straight line from the property's location to the point of interest or airport and may not reflect actual travel distance.
Distances are displayed to the nearest 0.1 km and mile.
Transportation services Comfort Inn Near Greenfield Village
- Shuttle service
- Free parking
We have the accommodation you need, all over the world
- • Hotel The Standard Downtown LA - Los Angeles, USA
- • Hotel Tyrolis - Zirl, Austria
- • Hotel Olivia - Leutasch, Austria
- • Hotel Hostellerie La Diligence - Obernai, France
- • Hotel Cristallago - Seefeld, Austria
- • Hotel Lords Plaza, Surat - Surat, India
- • Hotel Garni Klausnerhof - Seefeld, Austria
- • Comfort Inn And Suites - Orlando, USA
- • Hotel Koreth - Innsbruck, Austria
- • Inn Riad Sable Chaud - Marrakech, Morocco
- • Hotel Landgasthof Lilie - Reutte, Austria
- • Gasthof Innbrücke - Innsbruck, Austria
- • Hotel Maximilian Stadthaus Penz - Innsbruck, Austria
- • Hotel Trieste - Morbegno, Italy
- • Hotel Aulac - Lausanne, Switzerland
- • Andilly Hotels, France
- • Salon-de-Provence Hotels, France
- • Detroit Hotels, USA
- • Slave Lake Hotels, Canada
- • Fort Mcmurray Hotels, Canada
- • Penacova Hotels, Portugal
- • Lippstadt Hotels, Germany
- • Loutro Hotels, Greece
- • San Jose Hotels, USA
- • Orléans Hotels, France
- • Sicily – South Coast Hotels, Italy
- • Mórahalom Hotels, Hungary
- • Nice Hotels, France
- • Campegine Hotels, Italy
- • Dro Hotels, Italy


text:
Your email has been sent.
Teaching the Pre-Holocaust
Emerging pedagogy looks at life before wartime
A Vienna-based nonprofit, Centropa, is pushing a new way to teach the Holocaust to children: With the use of thousands of digitized photographs and other documents, you give kids a view of, in the words of one teacher, "the beautiful life of Jewish communities in Europe through personal stories. Students appreciate more what was lost and how diverse Jewish life was in Central and Eastern European life."
As long as we're plugging things Tablet Magazine editor-in-chief Alana Newhouse wrote in the New York Times, in April she published, in the paper's magazine, a look at the work of famed photographer Roman Vishniac, whose portraits of pre-Holocaust shtetl life may have oversimplified the Eastern European Jewish experience. "After the war, it became difficult to view prewar images as anything but a prelude to destruction," she wrote, "a backshadowing that distilled the complicated, multifaceted reality of prewar Jewish life into a two-dimensional shrine." A new look at Vishniac, Newhouse suggested, would bring about a fuller appreciation of the breadth of the culture that was wiped out.
In Teaching Holocaust, Educators Focus on Prewar Lives, Not Just Camps [JTA]
Related: A Closer Reading of Roman Vishniac
Out of Focus [Tablet Magazine]
Click here for access to comments
Daily rate: $2
Monthly rate: $18
Yearly rate: $180
Tablet is committed to bringing you the best, smartest, most enlightening and entertaining reporting and writing on Jewish life, all free of charge. We take pride in our community of readers, and are thrilled that you choose to engage with us in a way that is both thoughtful and thought-provoking. But the Internet, for all of its wonders, poses challenges to civilized and constructive discussion, allowing vocal—and, often, anonymous—minorities to drag it down with invective (and worse). Starting today, then, we are asking people who'd like to post comments on the site to pay a nominal fee—less a paywall than a gesture of your own commitment to the cause of great conversation. All proceeds go to helping us bring you the ambitious journalism that brought you here in the first place.
Readers can still interact with us free of charge via Facebook, Twitter, and our other social media channels, or write to us at firstname.lastname@example.com. Each week, we'll select the best letters and publish them in a new letters to the editor feature on the Scroll.
We hope this new largely symbolic measure will help us create a more pleasant and cultivated environment for all of our readers, and, as always, we thank you deeply for your support.


text:
Civil War Prison Camps and Prisoners of War
Eric Leonard talked about the rise of prison camps during the Civil War and the harsh life soldiers endured as prisoners of… read more
Eric Leonard talked about the rise of prison camps during the Civil War and the harsh life soldiers endured as prisoners of war. Mr. Leonard described how the prison camps were created and maintained, and he gave firsthand accounts of the horrors inside the prisons.
This talk was a presentation of the 2014 summer conference of the Civil War Institute at Gettysburg College, "The Civil War in 1864." close
*The transcript for this program was compiled from uncorrected Closed Captioning.
People in this video
- Eric Leonard Education Chief Andersonville National Historic Site
Hosting Organization
More Videos From
Civil War Institute at Gettysburg College Summer Conference - Day ThreeMore Videos
Related Video
U.S. Colored Troops and the Battle of the Crater
Emmanuel Dabney talked about the role of the U.S. Colored Troops in the Civil War Battle of the Crater during the siege…
1864 Atlanta Campaign
Professor Keith Bohannon talked about General William Tecumseh Sherman's 1864 Atlanta campaign. In the…
Ulysses S. Grant and Virginia in 1864
Professor Brooks Simpson talked about Union General Ulysses S. Grant's Overland Campaign, which was a series of…
Sand Creek Massacre
Professor Ari Kelman talked about the Sand Creek Massacre. The attack took place on November 29, 1864 when members…


text:
1. Age-related macular degeneration (ARMD or AMD) is a painless, insidious disease process of vision loss that is characterized by progressive degeneration of the macula, the central part of the retina at the back of the eye. ARMD, also known as the neovascular (wet) form of the disease, is the leading cause of irreversible, severe vision loss in people 55 years or older. This neovascular (wet) form of the disease represents approximately 10 percent of the overall disease prevalence, but is responsible for 90 percent of the severe vision loss. Though the cause of ARMD is not known, several risk factors have been identified: advanced age, hypertension, tobacco exposure, and/or history of vascular disease.
2. Neovascular ARMD is characterized by CNV that invades the subretinal space, often leading to exudation and hemorrhage. If the condition is left untreated, damage to photoreceptors and loss of central vision usually result, and after several months to years, the vessels are largely replaced by a fibrovascular scar. Patients in whom a central scotoma (vascular scar) develops have difficulty performing critical tasks that are typically associated with central vision, such as reading, driving, walking and recognizing faces.
3. Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of blindness in the working-age population of most developed countries. The increasing number of individuals with diabetes worldwide suggests that DR and DME will continue to be major contributors to vision loss and associated functional impairment for years to come. Early detection of retinopathy in individuals with diabetes is critical in preventing visual loss, but current methods of screening fail to identify a sizable number of high-risk patients. The control of diabetes-associated metabolic abnormalities (i.e., hyperglycemia, hyperlipidemia, and hypertension) is also important in preserving visual function because these conditions have been identified as risk factors for both the development and progression of DR or DME. The currently available interventions for DR or DME, laser photocoagulation and vitrectomy, only target advanced stages of disease. Several biochemical mechanisms, including protein kinase C–β activation, increased vascular endothelial growth factor production, oxidative stress, and accumulation of intracellular sorbitol and advanced glycosylation end products, may contribute to the vascular disruptions that characterize DR or DME. The inhibition of these pathways holds the promise of intervention for DR at earlier non–sight-threatening stages. To implement new therapies effectively, more individuals will need to be screened for DR or DME at earlier stages—a process requiring both improved technology and interdisciplinary cooperation among physicians caring for patients with diabetes.
Stages of Diabetic Retinopathy
4. Macular Edema occurs when fluid and protein deposits collect on or under the macula of the eye, a yellow central area of the retina, causing it to thicken and swell. The swelling may distort a person's central vision, as the macula is near the center of the retina at the back of the eyeball. This area holds tightly packed cones that provide sharp, clear central vision to enable a person to see form, color, and detail that is directly in the line of sight.
5. Cystoid macular edema (CME) is a painless disorder that affects the central retina or macula. When this condition is present, multiple cyst-like (cystoid) areas of fluid appear in the macula and cause retinal swelling or edema.
Although the exact cause of CME is not known, it may accompany a variety of diseases such as retinal vein occlusion, uveitis, or diabetes. It most commonly occurs after cataract surgery. About 1-3 % of those who have cataract extractions will experience decreased vision due to CME during the first post-operative year, usually from two to four months after surgery. If the disorder appears in one eye, there is an increased risk (possibly as high as 50%) that it will also affect the second eye. Fortunately, however, most patients recover their vision with treatment.
6. Central Retinal Vein Occlusion (CRVO) & Branch Retinal Vein Occlusion (BRVO) are common retinal vascular disorders. Clinically, CRVO presents with variable visual loss; the fundus may show retinal hemorrhages, dilated tortuous retinal veins, cotton-wool spots, macular edema, and optic disc edema. In view of the devastating complications associated with the severe form of CRVO, a number of classifications were described in the literature. All of these classifications take into account the area of retinal capillary non-perfusion and the development of neovascular complications. The signs of a BRAO are similar, but present in just one quadrant.
7. Myopic degeneration is a hereditary deformation of the eye that causes dramatically blurred vision or complete blindness. It is a severe form of simple myopia, which describes the common near-sightedness present in many people. Myopic degeneration is caused by the thinning, stretching and deformation of the sclera. When the sclera weakens due to inherited degenerative myopia, structures such as the macula and retina become damaged.
8. Angioid Streaks (idiopathic, secondary to toxoplasmosis, trauma). Angioid streaks are linear gray, brown, or red-brown lines that extend radially from the optic disc and are located at the level of Bruch's membrane. These streaks usually are associated with peripapillary atrophic retinal pigment epithelium (RPE) changes surrounding the optic disc. Angioid streaks may not be readily visible or may be more extensive than apparent by ophthalmoscopic examination alone. Patients may present with vision loss when a streak extends into the fovea or when choroidal neovascularization develops in the macula, most commonly at the distal tip of an angioid streak. Angioid streaks may be idiopathic or may be associated with systemic disorders such as pseudoxanthoma elasticum, Paget's disease, Ehlers-Danlos syndrome, or sickle cell disease.
Each benefit plan, summary plan description or contract defines which services are covered, which services are excluded, and which services are subject to dollar caps or other limitations, conditions or exclusions. Members and their providers have the responsibility for consulting the member's benefit plan, summary plan description or contract to determine if there are any exclusions or other benefit limitations applicable to this service or supply. If there is a discrepancy between a Medical Policy and a member's benefit plan, summary plan description or contract, the benefit plan, summary plan description or contract will govern.
Verteporfin (Visudyne™)
Visudyne may be considered medically necessary as a Food and Drug Administration (FDA) off-label indication for:
Visudyne is considered experimental, investigational and unproven for all other indications.
Pegaptanib sodium injection (Macugen®)
Macugen may be considered medically necessary as an FDA labeled indication for the treatment of neovascular (wet) ARMD.
Macugen may be considered medically necessary as an FDA off-label indication for the treatment of diabetic macular edema and diabetic retinopathy.
Macugen is considered experimental, investigational and unproven for all other indications.
Ranibizumab injection (Lucentis™)
Lucentis may be considered medically necessary as an FDA labeled indication for the treatment of:
Lucentis is considered experimental, investigational and unproven as a treatment for all other indications.
Aflibercept injection (Eylea™)
Eylea may be considered medically necessary for treatment of the following FDA labeled indications:
Eylea is considered experimental, investigational and unproven for all other ophthalmologic indications.
Bevacizumab (Avastin™)
Avastin may be considered medically necessary as an FDA off-label indication for the treatment of:
Avastin is considered experimental, investigational and unproven for all other ophthalmologic indications.
Conjunctival incision with posterior juxtascleral placement of Anecortave Acetate (Retaane™) is considered experimental, investigational and unproven as a treatment of neovascular (wet) ARMD or AMD.
Delivery of pharmacologic agents into the suprachoroidal space of the eye by injection or microcannulation is considered experimental, investigational and unproven.
Verteporfin photodynamic therapy received FDA approval in 2000 for the treatment of "predominantly classic subfoveal choroidal neovascularization associated with ARMD." Therefore, the labeled indications for Visudyne and Macugen overlap, although Macugen includes a broader range of patients with ARMD.
While there is no direct comparison with Visudyne therapy, the randomized studies used for both Visudyne and Macugen therapy incorporated the same primary outcome. After one year of follow-up in the randomized study of Visudyne, 61 percent of the treated patients lost less than 15 letters of acuity, versus 46 percent in the placebo group. After two years, 53 percent of the treatment group versus 38 percent of the placebo group lost fewer than 15 letters.
It is not clear how providers may choose to offer either Macugen or Visudyne. One major difference between the two is that Macugen requires intravitreal injections while Visudyne requires intravenous injection followed by laser therapy. In the randomized trials, Macugen was administered every six weeks, in contrast to Visudyne which is administered once, with follow-up every three months, with additional treatment if neovascularization recurs. Many ophthalmologists are now familiar with administering Visudyne therapy, and given the apparently equivalent results of the two drugs, many may continue to preferentially offer Visudyne. Patient preference will also play a role. In the randomized studies of Macugen, patients were allowed to undergo concomitant Visudyne therapy, so it is likely that some patients will continue to receive both therapies.
FDA approval of Macugen was based in part on the results of two similarly designed randomized trials. The results of these studies were published in the New England Journal of Medicine in 2004. Patients were randomized to receive control (placebo treatment) or one of three different doses of Macugen administered as intravitreous injections every six weeks for 48 weeks. Patients were re-randomized between treatment and no-treatment groups during the second year of the trial. The primary outcome was the proportion of patients losing less than 15 letters of visual acuity, from baseline up to 54 week assessment. After the first year in one study, 73 percent of patients in the treatment group lost less than 15 letters of acuity versus 60 percent sham, and 67 percent versus 53 percent in the second randomized trial, both statistically significant results. Macugen was less effective during the second year of the trial, with 57 percent of the treatment group losing less than 15 letters of vision, compared to 56 percent in the sham group in one trial, and 61 percent versus 34 percent in the second trial.
The study entry criteria for Macugen trials were quite broad including patients whose vision ranged from 20/40 to 20/320. While 20/40 vision is required for such routine activities as reading or driving, 20/320 vision represents legal blindness. Therefore, the functional impact of preservation of visual acuity will be quite different at different ends of the spectrum. For example, preservation of vision to a level of 20/100 suggests that with optical assistance, a patient could perform reasonably well. However, preservation of 20/400 vision would provide only very limited function. While patients with greater vision impairment at initiation of therapy also appeared to benefit from Macugen therapy (in terms of visual acuity as measured by number of letters lost), there was no discussion of functional outcomes.
Macugen is a selective RNA aptamer that inhibits vascular endothelial growth factor (VEGF) 165, the VEGF isoform primarily responsible for pathologic ocular neovascularization and vascular permeability, while sparing the physiological isoform VEGF 121. After more than 10 years in development and preclinical study, pegaptanib was shown in clinical trials to be effective in treating CNV associated with ARMD. Its excellent ocular and systemic safety profile has also been confirmed in patients receiving up to three years of therapy. Early, well-controlled studies further suggest that pegaptanib may provide therapeutic benefit for patients with DME, proliferative DR and retinal vein occlusion. Notably, pegaptanib was the first available aptamer approved for therapeutic use in humans and the first VEGF inhibitor for the treatment of ocular vascular diseases.
Administration of intravitreal pegaptanib (Cunningham et al.) led to an improvement in visual acuity and a reduction in central retinal thickness in some patients with early stage DME in a randomized, double-blind, dose-finding, phase II trial. Pegaptanib-treated patients received an average of five injections, with 49% (83/172) receiving the maximum of six injections. Of the patients receiving the active study regimen, the patients allocated to the 0.3 mg dose had greater improvement in vision acuity, greater decrease in retinal thickness, and lesser need for focal or grid laser intervention.
FDA approval of Lucentis for ARMD was based on three, double-masked sham or active-controlled clinical trials in patients with neovascular AMD (combined n=1323). In the first study, patients with minimally classic or occult CNV lesions received monthly intravitreal injections of Lucentis (0.3mg or 0.5mg) or monthly sham injections over a 24-month period. In a second study, patients with predominantly classic CNV lesions received one of the following:
The primary efficacy endpoint was the proportion of patients who maintained vision, defined as losing fewer than 15 letters of visual acuity at 12 months compared with baseline. Almost all Lucentis-treated patients (approximately 95%) maintained their visual acuity. Thirty-four percent to 40% of Lucentis-treated patients experienced a clinically significant improvement in vision, defined as gaining 15 or more letters at 12 months. The size of the lesion did not significantly affect the results. In the third study (n=184), patients with neovascular AMD (with or without a classic CNV component) received Lucentis 0.3mg (n=60) or 0.5 mg (n=61) intravitreal injections or sham (n=63) injections once a month for three consecutive doses, followed by a dose administered every 12 months. The primary efficacy endpoint was mean change in visual acuity (following monthly dosing), on average, patients dosed once every three months with Lucentis lost visual acuity, returning to baseline at month 12. Ninety percent of Lucentis-treated patients maintained their visual acuity at month 12.
On June 22, 2010 the FDA approved Lucentis® for the treatment of macular edema following retinal vein occlusion (RVO). RVO is the second most common retinal vascular disease after diabetic retinopathy. RVO affects as many as 180,000 people in the United States and macular edema leads to vision loss in many patients with either central or branch retinal vein occlusion (CRVO or BRVO). Accounting for approximately 80% of RVO, BRVO is the more common of the two presentations.
Two phase III clinical trials (BRAVO and CRUISE) studied the effects of intravitreal Lucentis measured over a period of six months. In the BRAVO study 61% of the patients in the Lucentis study arm gained 15 or more letters in BCVA from baseline at six months compared with only 29% in the sham injection arm. In the CRUISE study 48% of the patients in the Lucentis study arm gained 15 or more letters in BCVA from baseline at six months compared to only 17% in the sham injection arm. These results demonstrated that in macular edema due to RVO, patients who were treated with Lucentis made significant improvement in best-corrected visual acuity (BCVA).
On August 10, 2012 the Food and Drug Administration (FDA) approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease that occurs in people with diabetes.
The safety and efficacy of Lucentis were assessed in two randomized, double-masked, 3-year studies in patients with DME. The studies were sham-controlled through Month 24. Patient age ranged from 21 to 91 years, with a mean age of 62 years. A total of 759 patients (Lucentis 0.3 mg, 250 patients; Lucentis 0.5 mg, 252 patients; sham, 257 patients) were enrolled, with 582 (77%) completing through Month 36. In Studies DME-1 and DME-2, patients received monthly Lucentis 0.3 mg or 0.5 mg intravitreal injections or monthly sham injections during the 24-month controlled treatment period. From Months 25 through 36, patients who previously received sham were eligible to receive monthly Lucentis 0.5 mg and patients originally randomized to monthly Lucentis 0.3 mg or 0.5 mg continued to receive their assigned dose. All patients were eligible for macular focal/grid laser treatment beginning at Month 3 of the 24-month treatment period or panretinal photocoagulation (PRP) as needed. Through Month 24, macular focal/grid laser treatment was administered in 94 of 250 (38%) patients treated with Lucentis 0.3 mg and 185 of 257 (72%) patients treated with sham; PRP was administered in 2 of 250 (1%) patients treated with Lucentis 0.3 mg and 30 of 257 (12%) patients treated with sham. Compared to monthly Lucentis 0.3 mg, no additional benefit was observed with monthly treatment with Lucentis 0.5 mg.
Visual acuity (VA) outcomes observed at Month 24 in patients treated with Lucentis 0.3 mg were maintained with continued treatment through Month 36 in both DME studies. Patients in the sham arms who received Lucentis 0.5 mg beginning at Month 25 achieved lesser VA gains compared to patients who began treatment with Lucentis at the beginning of the studies.
On November 18, 2011, the Food and Drug Administration (FDA) approved Eylea™ (aflibercept) previously called VEGF Trap-Eye for the treatment of "wet" (neovascular) age-related macular degeneration (ARMD, AMD), a leading cause of vision loss and blindness in Americans ages 60 and older. The safety and effectiveness of Eylea was evaluated in two clinical trials involving 2,412 adult patients. Patients in the study received either Eylea or Lucentis (ranibizumab injection). The primary endpoint in each study was a patient's clearness of vision (visual acuity) after one year of treatment.
A total of 2,457 patients were randomized in the two clinical trials of Eylea, with more than 90% completing the year-long study. Maintenance of visual acuity was similar between aflibercept and ranibizumab in the multicenter, randomized, double-masked, active-controlled VIEW1 and VIEW2 studies for the treatment of neovascular (wet) age-related macular degeneration (n=2412; mean age, 76 years; range, 49 to 99 years). Patients were randomized to receive intravitreal injections of aflibercept 2 mg every eight weeks following three initial monthly doses (n=301), 2 mg every four weeks (n=304), 0.5 mg every four weeks, or ranibizumab 0.5 mg every four weeks (n=304) in VIEW1 and VIEW2 (n=306, n=309, and n=291, respectively). Data from the aflibercept 0.5 mg every four weeks treatment arm was not reported. Of evaluable patients in VIEW1 at 52 weeks, the proportion of patients who maintained visual acuity (less than 15 letter loss of best corrected visual acuity (BCVA) from baseline; primary outcome) was 94%, 95%, and 94% in the aflibercept eight-week arm, four-week arm, and ranibizumab four-week arm, respectively. In VIEW1, the treatment difference at 52 weeks between aflibercept every eight weeks and ranibizumab was 0.6 letters (95.1% confidence interval (CI), -3.2 to 4.4 letters), and the difference between aflibercept every four weeks and ranibizumab was 1.3 letters (95%.1 CI, -2.4 to 5 letters). Similarly, in VIEW2 at 52 weeks, the proportion of patients who maintained visual acuity was 95% among all treatment arms. In VIEW2, the treatment difference at 52 weeks between aflibercept every eight weeks and ranibizumab was 0.6 (95.1% CI, -2.9 to 4 letters), and the difference between aflibercept every four weeks and ranibizumab was -0.3 (95.1% CI, -4 to 3.3 letters). The proportion of patients who gained at least 15 letters of vision from baseline was similar for aflibercept eight-week and four-week arms and ranibizumab in VIEW1 (31%, 38%, and 31%, respectively) and in VIEW2 (31%, 29%, and 34%, respectively). The mean change in BCVA (Early Treatment Diabetic Retinopathy Study) was also similar among all arms in VIEW1 and VIEW2.
Ophthalmologists are using Avastin off-label to treat AMD and similar conditions since research indicates that VEGF is one of the causes for the growth of the abnormal vessels that cause these conditions. Some patients treated with Avastin had less fluid and more normal-appearing maculas, and their vision improved. Avastin is also used to treat macular edema or swelling of the macula.
Intravitreal use of Avastin involves both an off-label application of the drug and an alternative route of drug delivery. Positive presentations at retinal meetings and the two published case reports of visual acuity improvement and decreased retinal thickness have led the retinal community to embrace this new treatment. As a result, the use of intravitreal Avastin has increased exponentially. The main force driving intravitreal Avastin usage is the high percentage of patients who experience symptomatic relief from active subfoveal CNV.
Because Avastin was not created to be given as an intraocular injection, there have been no published animal or human safety data on retinal toxicity. The intraocular safety profile of Avastin is unknown in contrast to that of Macugen or even Lucentis. Avastin is also a full-sized antibody, unlike the Lucentis fragment, which means there is more potential for inflammation and immune reactions to this larger molecule over time. The longer half-life (up to 20 days) of Avastin is useful for systemic cancer but may cause safety concerns in the eye. (In contrast, the half-life of Lucentis was targeted for four hours.) Whether systemic absorption is more likely with a longer half-life drug is unknown. Although an intravitreal injection uses minute fractions of the drug and the systemic absorption is unlikely to be significant, measurement of systemic levels after intravitreal injection has not been done. The clearance of Avastin is 100-fold slower than Lucentis, and the affinity of Avastin for VEGF is less than that of Lucentis. Reasons to use Avastin center on fast onset of improved retinal morphology and visual acuity. The anecdotal report showed dramatic improvement in optical coherence tomography appearance and corresponding improvement in visual acuity. Other reasons to use it include its low cost and wide availability, with no unexpected toxicity shown to date. Applications of its use include:
For patients who have failed therapy with approved drugs and have not yet evolved to disciform scars, off-label Avastin could be recommended as a salvage therapy. Of all of these reasons, the overwhelming reason to use it is, of course, efficacy.
Considerations surrounding the use of anti-VEGF agents for neovascular glaucoma include safety, the most effective dose, the best route of administration, and utility as adjuvant therapy to panretinal photocoagulation (PRP), surgical filtration, or cyclodestructive procedures. Studies suggest that the risk of endophthalmitis is extremely small; reported rates include 0.1% and 0.019%. The preferred route of administration currently is intravitreal, and the recommended dose of Avastin for neovascular glaucoma is 1.25 mg.
The Retaane clinical study was a blinded, randomized controlled trial, with an enrollment of 128 patients with subfoveal CNV at 18 clinical sites, followed up patients for two years, and was completed in June 2003. The study eye was randomized to 30 mg, 15 mg, 3 mg, or placebo from a central coordinating center. Retaane or placebo was administered at baseline; retreatment at the six month visit occurred at the discretion of an unmasked ophthalmologist based on perceived benefit. Compared to placebo, 15 mg (the most efficacious dose) was accompanied by a 25.5% absolute risk benefit for losing fewer than 15 letters of visual acuity. No serious clinically relevant-treatment-related safety issues were reported from either the study medication Retaane or the procedure for administration. Adverse ocular events seen in excess in patients treated with Retaane versus placebo were 15.3% excess of vision abnormalities and 7.1% excess of ocular foreign body sensation. Cataracts were found in 27% and 30% and decreased visual acuity was noted in 25% and 30% in the treatment and placebo groups, respectively. These occurrences included only study eyes, untreated eyes, or both eyes and are commonly experienced in patients with AMD. Other adverse events that were reported as mild and transient included ptosis, ocular pain, visual abnormalities (e.g. hazy vision, black spots, light flashes), subconjunctival hemorrhage, and ocular pruritus.
A phase III randomized control trial compared the one-year safety and efficacy of Retaane 15 mg with photodynamic therapy (PDT) with Visudyne in 530 patients with predominantly classic CNV. Retaane 15 mg was comparable to PDT for maintaining vision, with no statistical difference in the responder rates between the two groups. Percent responders, defined as patients losing less than three lines of vision at month 12, in the Retaane 15 mg and PDT groups were 45% and 49% respectively. The month 12 outcome of Retaane was improved in patients for whom reflux was controlled and who were treated within the six month window. The most frequently reported adverse event in both treatment groups was decreased visual acuity, defined as a loss of vision of plus or minus four lines from the previous visit, occurring at an incidence of 31.9% and 30.3%, respectively.
Traditional methods of ocular drug delivery include topical application, intraocular injection and systemic administration however these methods have difficulty effectively delivering drugs to the back (posterior portion) of the eye. Current animal studies show promise of a drug delivery system using the suprachoroidal space of the eye that may avoid the complications associated with intraocular injection and systemic administration.
Clinical trials are currently investigating the potential use of suprachoroidal drug delivery to the posterior pole (macula and optic nerve) using an advanced microcannula system and demonstrated relative safety by studying the choroidal and retinal blood flow with high-speed confocal Scanning Laser Ophthalmoscope (cSLO) video angiography, fundus exam by cSLO imaging and wide-field fundus photography, and short- and long-term histopathology in the pig model. These data have been used to justify the safety of this methodology for use in humans. Clinical trials are currently investigating the potential use of this technology for treatment of macular disease.
A study by Einmahl et al. investigated the feasibility and tolerance of suprachoroidal delivery of poly ortho ester (POE), a bioerodible and biocompatible polymer, as a biomaterial potentially useful for development of sustained drug delivery systems. The authors concluded that POE suprachoroidal injections, an easy, controllable, and reproducible procedure, were well tolerated in the rabbit eye. POE appears to be a promising biomaterial to deliver drugs focally to the choroid and the retina.
Another study by Olsen et al. in 2006 evaluated the pharmacokinetics of a posterior drug delivery system (PDS) by means of microcannulation of the suprachoroidal space in both the primate and pig animal model. Cannulation was performed in 93 of 94 animals. Complications included: endophthalmitis (1/94), choroidal tear (1/94), choroidal blood flow irregularities (4/94), postoperative inflammation (6/94), scleral ectasia (4/94), wound abscess (1/94), and others. Histopathology demonstrated normal anatomy in uncomplicated cases. Triamcinolone remains in the local ocular tissue for at least 120 days, and measurable at very low levels in the systemic circulation. The authors concluded accessing the suprachoroidal space by the microcannulation system can be performed in a safe and reproducible manner by using careful surgical technique. Forceful PDS tip impact into connective tissues in the macular and optic nerve regions should be avoided. Triamcinolone pharmacokinetics is unique and suggests long-term local tissue levels with low systemic levels. PDS access to the suprachoroidal space represents a novel drug delivery method; applicable to a wide variety of pharmacotherapy's to the macula, optic nerve, and posterior pole.
The published literature to date does not permit scientific conclusions concerning the effects of suprachoroidal delivery of pharmacologic agents on health outcomes in humans.
On September 21, 2012, the FDA granted approval of Aflibercept injection (Eylea®) for the treatment of macular edema following central retinal vein occlusion (CRVO).
Disclaimer for coding information on Medical Policies
Procedure and diagnosis codes on Medical Policy documents are included only as a general reference tool for each policy. They may not be all-inclusive.
The presence or absence of procedure, service, supply, device or diagnosis codes in a Medical Policy document has no relevance for determination of benefit coverage for members or reimbursement for providers. Only the written coverage position in a medical policy should be used for such determinations.
Benefit coverage determinations based on written Medical Policy coverage positions must include review of the member's benefit contract or Summary Plan Description (SPD) for defined coverage vs. non-coverage, benefit exclusions, and benefit limitations such as dollar or duration caps.
14.29, 14.75, 14.9, 360.21, 362.0-362.07, 362.50, 362.51, 362.52, 364.42


text:
Tropical storm skirts PH, heads for Japan, but brings rain to Luzon, Visayas
MANILA, Philippines—Tropical Storm "Man-Yi" is heading for Japan but is expected to continue to enhance the southwest monsoon (habagat) and bring moderate to heavy rains over portions of Luzon and the Visayas on Monday.
The weather bureau alerted residents of Metro Manila as well as Central and southern Luzon to possible flash floods and landslides that may be triggered by the rains.
Meanwhile, the Philippine Atmospheric, Geophysical and Astronomical Services Administration (Pagasa) is tracking a low pressure area (LPA) east of Luzon.
The LPA was monitored at 4 p.m. Sunday to be 1,010 kms east of Luzon. "Based on our assessment, it could develop into a tropical depression as long as it remains over the Pacific Ocean," forecaster Buddy Javier said, adding that the LPA was not anticipated to intensify into a tropical cyclone within the next 48 hours.
The weather agency said the current rainy weather was due to storm Man-Yi, which skirted the Philippine area of responsibility.—Jeannette I. Andrade
Get Inquirer updates while on the go, add us on these apps:
Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of INQUIRER.net. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City,Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94


text:
Book your room at Peixin Hotel
Please enter your travel dates.
4-star Beijing hotel in Chongwen, near Hongqiao Market
Located in Chongwen, this hotel is within 3 mi (5 km) of Hongqiao Market, Tiananmen Square, and Temple of Heaven. China Museum of History and Chairman Mao Memorial Hall are also within 3 mi (5 km).
Hotel Features
This hotel features a restaurant, a fitness center, and conference rooms. WiFi in public areas is free. Other amenities include meeting rooms, dry cleaning, and a 24-hour front desk.
Room Amenities
All 174 rooms feature thoughtful touches like bathrobes and slippers, plus free WiFi, free wired Internet, and LCD TVs with satellite channels. Minibars, coffee makers, and free bottled water are among the other amenities available to guests.Information missing or incorrect? Tell us!
Hotel Amenities
Hotel Amenities
The hotel offers a restaurant. Public areas are equipped with complimentary high-speed wireless Internet access. Event facilities include conference space and meeting rooms. This Beijing hotel also offers a fitness center, tour/ticket assistance, and dry cleaning/laundry services.
- Year Built 1999
- Meeting rooms
- Number of meeting rooms - 13
- Parking (limited spaces)
- Luggage storage
- Tours/ticket assistance
- Free WiFi
- Express check-in
- Porter/bellhop
- Express check-out
- Dry cleaning/laundry service
- Breakfast available (surcharge)
- Elevator/lift
- Fitness facilities
- Hair salon
- ATM/banking
- Total number of rooms - 174
- Number of buildings/towers - 12
- 24-hour front desk
- Conference space
- Restaurant
Family Friendly Amenities
- Free Wi-Fi
- Rollaway/extra beds available
- Cribs/infant beds (complimentary)
Available in all rooms: Free WiFi , Free wired high-speed Internet
Available in some public areas: Free WiFi
Parking (limited spaces)
Room Amenities
- Shower/tub combination
- Free cribs/infant beds
- Phone
- Private bathroom
- Free toiletries
- In-room safe
- Desk
- Rollaway/extra beds available
- Iron/ironing board (on request)
- Slippers
- Free WiFi
- Climate control
- Air conditioning
- Minibar
- Coffee/tea maker
- Free bottled water
- Daily housekeeping
- Turndown service
- Hair dryer
- Bathrobes
- Satellite TV service
- Free wired high-speed Internet
Where to Eat
Buffet breakfasts are available for a surcharge and are served each morning between 6:30 AM and 10 AM.
Chinese Restaurant - This restaurant specializes in Chinese cuisine and serves lunch and dinner.
To make requests for specific accessibility needs, complete the "Special or Accessibility Requests" section of "Trip Preferences" when you book your hotel.
- Accessible path of travel
- Accessible bathroom
- In-room accessibility
Hotel Policies
Minimum check-in age is 18
Check-in time starts at noon
Check-out time is noon
Payment types
Children and extra beds
- Children are welcome.
- Rollaway/extra beds are available for CNY 200 per night.
- Free cribs (infant beds)!
You need to know
Extra-person charges may apply and vary depending on hotel policy.
Government-issued photo identification and a credit card or cash deposit are required at check-in for incidental charges.
Special requests are subject to availability upon check-in and may incur additional charges. Special requests cannot be guaranteed.
- Fee for buffet breakfast: CNY 58 per person (approximately)
- Rollaway bed fee: CNY 200 per night


text:
NBA free agency begins with major names on market
JUN 30, 2014 2:45p ET
The "Wild West" of basketball known as NBA free agency begins Tuesday at 12:01 a.m. EST. Here's a look at the best of the bunch:
1. LeBron James, F, Miami Heat, unrestricted
All signs point to the King of Basketball returning to the Heat, but you have to wonder if that's really the best situation for him. If he gives others the chance to recruit him, and he truly wants a maximum contract, he might be able to be swayed to join a roster that's younger and an organization with more flexibility. Insert LeBron, and any team immediately becomes a title contender. Predicted frontrunner: Miami.
2. Carmelo Anthony, F, New York Knicks, unrestricted
He can still light up the opposition like Bernard King on caffeine, but what else does Anthony actually offer? It's hard to say, but he'd better get it figured out quick. He's running out of time to chase titles, and New York may not be his best option for that. Predicted frontrunner: Chicago.
3. Dirk Nowitzki, PF, Dallas Mavericks, unrestricted
Just turned 36 years old and guess what? It doesn't matter. He's still near the very top of his well-rounded and all-pro-level game. But don't get your hopes up. He's going back to the Mavs. Predicted frontrunner: Dallas.
4. Chris Bosh, PF, Miami Heat, unrestricted
Has taken serious flak for accepting a reduced role in his four years with the Heat, but could still be a top option in some spots and a good 1-A in others. If LeBron goes elsewhere, expect Bosh to do the same. A run from the Lakers isn't out of the question. Predicted frontrunner: Miami.
5. Kyle Lowry, PG, Toronto Raptors, unrestricted
Coming off a breakout season in which he helped lift the surprising Raptors to the third season in the East. A complete and underrated point guard who will run the team and defend. He's in high demand, but the Raptors are making him their top priority. Predicted frontrunner: Toronto.
6. Eric Bledsoe, PG, Phoenix Suns, restricted
Is slowly becoming what Dwyane Wade used to be, as Bledsoe can play both guard spots, defend and works tirelessly on his game. He's also been called quite "coachable," which only increases his value. So it's hard to see the Suns letting him get away. Predicted frontrunner: Phoenix.
7. Chandler Parsons, F, Houston Rockets, restricted
Good athlete with all the tools, may be even better on a team without top options Dwight Howard and James Harden. With those two on the roster, and the Rockets seemingly intent on making a run at James or Anthony, Parsons could be a goner. But to where, no one yet knows. Predicted frontrunner: TBD.
8. Greg Monroe, PF/C, Detroit Pistons, restricted
Big, young and talented. That's hard to beat. The trouble with Monrue is he may have peaked, and he's not quite at an All-Star level. But he is a good, starter-worthy big man. If you don't think those are hot commodities, check out the deal Roy Hibbert got last summer. Predicted frontrunner: Detroit.
9. Pau Gasol, PF, Los Angeles Lakers, unrestricted
Not the player he once was, but can still be very good in spurts. If he can stay healthy, he's an impact starter and a "stretch four" who can still run the court and finish. Teams will be hot on his trail based on those things alone. Predicted frontrunner: Memphis.
10. Lance Stephenson, SG, Indiana Pacers, unrestricted
He can really play, but beyond that, it's hard to tell what you're getting. A really good guy who can sometimes seems like more trouble than he's a worth. He is, truly, a mystery. But a talented mystery nonetheless. Predicted frontrunner: Indiana.
11. Dwyane Wade, SG, Miami Heat, unrestricted
Skills have eroded to the point where he probably doesn't deserve more than the veteran minimum. Yet for some reason he opted out of $20 million -- presumably to re-work his deal and allow James and Bosh to return. But in all honesty, Heat would be best served to re-sign James and Bosh, and a third leg of the Big Three not named Wade. Predicted frontrunner: Miami.
12. Luol Deng, SF, Cleveland Cavaliers, unrestricted
Coming off the worst stretch in his career under Mike Brown. That happens to a lot of guys on offense, and teams in pursuit will be willing to give Deng a pass. But he also looked a little slower, and there may be a reason the Bulls were so willing to give him up. Predicted frontrunner: Atlanta.
13. Paul Pierce, F, Brooklyn Nets, unrestricted
He can still get it done. That's what teams in contention know and appreciate. Pierce may take less to go to the right spot. His priority is said to be Brooklyn, but he supposedly can be charmed into changing his mind. Predicted frontrunner: LA Lakers.
14. Gordon Hayward, F/G, Utah Jazz, restricted
Just now starting to come into his own and approach an All-Star level. And now he has a new coach in Quin Snyder that intends to keep Hayward a major part of things. The Jazz have the lead, but don't be surprised if someone swoops in and makes him a major offer. Predicted frontrunner: Utah.
15. Marcin Gortat, C, Washington Wizards
Hustling big man often does a lot with only a limited amount of looks at the basket. He runs the floor and chases down rebounds and actually has real basketball skills. His problem is an irritating lack of consistency. Predicted frontrunner: Washington.
Isiah Thomas, PG, Sacramento Kings, restricted
Boris Diaw, PF, San Antonio Spurs, unrestricted
Trevor Ariza, SF, Washington Wizards, unrestricted
Nick Young, SG, Los Angeles Lakers, unrestricted
Spencer Hawes, C, Cleveland Cavaliers, unrestricted
Evan Turner, SF, Indiana Pacers, unrestricted
Josh McRoberts, PF, Charlotte Hornets, unrestricted
Danny Granger, SF, Los Angeles Clippers, unrestricted
Ramon Sessions, PG, Milwaukee Bucks, unrestricted
Ray Allen, SG, Miami Heat, unrestricted
Shawn Marion, SF, Dallas Mavericks, unrestricted
Vince Carter, SG, Dallas Mavericks, unrestricted
Shaun Livingston, PG, Brooklyn Nets, unrestricted
Kris Humphries, PF, Boston Celtics, unrestricted
Andray Blatche, PF/C, Brooklyn Nets, unrestricted
Channing Frye, PF/C, Phoenix Suns, unrestricted
Marvin Williams, SF, Utah Jazz, unrestricted
Ed Davis, PF, Memphis Grizzlies, restricted
C.J. Miles, SG, Cleveland Cavaliers, unrestricted
Patty Mills, G, San Antonio Spurs, unrestricted
Kirk Hinrich, PG, Chicago Bulls, unrestricted
Jordan Hill, PF, Los Angeles Lakers, unrestricted
Mario Chalmers, PG, Miami Heat, unrestricted
Mike Miller, SG, Memphis Grizzlies, unrestricted
Mo Williams, PG, Portland Trail Blazers, unrestricted
Jordan Crawford, G, Golden State Warriors, restricted


text:
It's been awhile since we've hosted Handmade Holidays, but we're pleased to do so once again. If you missed us during this year's Autumn Drive, we hope you'll come out for a visit this Friday or Saturday during normal hours. If you need us to stay open longer for you one of those nights, we can do that do if you'll give us a holler. We are closed Sunday.
During Handmade Holidays, you'll find woolen goods that we make ourselves, by hand, using the fleece of our own icelandic sheep and the icelandic flock of Holly Marks, pastured in Elizabeth, Illinois. There is handmade quality for every budget, ranging from $18 and under to $450.00. This year, we are excited to offer Holly's outstanding icelandic lamb roving at $3.50/oz, in a variety of unusual moorits and greys. The last batch of 2014 raspberry jam will be available. New this year: I have been working on more one-of-a-kind felt wall art featuring wildlife, which I really love to do but don't often have enough time; and some smaller things like hand-dyed, embellished silk amulet necklaces stuffed with lavender. Mike has a cherry log bench available for $250, a "Cape Racer" sled for $250, and a marblewood skeinwinder for $50.
We'll be in the barn. Hope to see you! Meanwhile check out some of the stuff you'll find here:


text:
All banks, regardless of size, must invest more in technology despite shareholder pressure to cut costs, said Victor Nichols, a former CIO at Wells Fargo and current director at Bank of Hawaii.
No One's Safe from Cyberattacks: Former Wells Fargo CIO
AUG 28, 2014 12:23pm ET
To continue, please log in, register or subscribe.
Already a subscriber? Log in here


text:
Chanel UV Essentiel Protective UV Care Anti Pollution SPF 50
84 reviews
72% would repurchase
Package Quality: 4.4
Price: $$$$
Package Quality: 4.4
Price: $$$$
INGREDIENTScyclopentaxiloxane, zinc oxide (19%) , aqua, ethylhexyl methoxynamate (7.5%), alchohol denat, isononyl isonanoate, dipropyleneglcol,glycerin, neopenthyl glycol dicaprate, polymethilsilsesquioxane, polymethyl methacrylate, dimeticone, triethoxycaprylylsilane, PEG-9polydimethylsiloxethl dimethicone, propylene glycol, thocopheryi acetate, butyleneglycol, parfum, hydrolyzed wheat protein, mannitol, dimethicone/vinyl dimethicone crosspolymere, methylparabean, glycogen, panax ginseng root extract, aesculus hippocastanum eed exract, tilia cordata wood extract, trimethoxycaprylylsilane, sodium citrate, sodium hyaluronate, chlorphenesin, Faex,bht, peg -40 hydrogenated castor oil, glycyrrhiza glabra extract, phenoxyethanol, calcium panthothenate, biotin, butylparaben, ethylparaben, propylparaben, titanium dioxide.
on 6/17/2010 9:13:00 PM
Age: 36-43
Skin: Combination, Tan, Warm
Hair: Brunette, Straight, Medium
Eyes: Brown
Love this product! I have combination skin and is prone to breakouts. Used this everyday for at least two weeks in the summer time with no problem. I don't have to use much to cover my whole face and it did not leave a white film on my face. After doing some research, Zinc oxide is one of the best physical sunblocks out there, and it does not degrade over time which is very important to me. For me, this product is worth the money!
on 5/29/2010 10:27:00 PM
Age: 30-35
Skin: Dry, Fair-Medium, Neutral
Hair: Brunette, Wavy, Fine
Eyes: Green
Such a mixed review for this one. Sunscreen is such an important part of anyone's skincare whether its in the hopes of stopping aging in its tracks or preventing skin cancer.
When it comes to my face my requirements are thus:
Shine free
Does not migrate into the eyes
Contains extra goodies in the form of antioxidants or ahas
No obvious white cast
Don't break the bank!
In terms of the first, Chanel is the best I have come across (I've tried more than I've cared to review!) Even my nose was shine free for over four hours, impressive stuff when I have the most shiny nose! However here's the cloud for that silver lining - as with anything that mattifies, it shows up every little flake on your face, especially around the eyes. You must make sure you are using a fab moisturisor underneath and exfoliate! I am currently loving St Ives firming scrub - see review) which is very gentle for the face but removes all the flakes from my Roc and Aha'd to hell and back face!
Next - It does not migrate into the eyes - joy! You do not have to purchase an extra eye sunscreen - looking at you Aveeno 30+ !! Grr.
It contains loads of extra goodies for the face and has helped to keep damage at bay as my face is super sensitive as I'm trying to get rid of my melasma from two pregnancies.
It does leave a white cast but it absorbs within 30 minutes or so.
And the final downer - I'm lucky I have a very understanding husband who smiles at my purchases instead of turning red. At $71 NZ for a teeny tiny bottle, it makes you gulp before you hand over your money that is for sure. I only use it for my face, not neck and for days I'm wearing makeup, if I'm at home I'm going to put on the Aveeno and blink furiously hoping that my eyes will stop stinging soon!
I am going to say that, no, I will not purchase again as I want to try ego's matte sunscreen with the purple stripe going across the bottle and then maybe some other higher end brands like 'to save face' spf 30+ which also dries to a matte finish but also has moisturising properties before I fold and go back to this one again.
on 4/25/2010 3:49:00 AM
Age: 30-35
Skin: Combination, Other, Not Sure
Hair: Blond, Other, Other
Eyes: Blue
Very thin liquid with high degree of protection. A bit similar to La Roche Posay (fluid extreme). You also need to shake a bottle before application. Less shiny than most of the sunscreens (inclusive of the Fluid Extreme by LRP), but leaves my face just slightly white\humid, thus not particularly ideal. Still it is ideally fixed with a dust of powder. But I have oily, problem skin and for me finding a skincare that actually absorbs 100% is difficult. In comparison with many others I`ve tried - this one is a winner.
When buying it I had a chance to compare it with another high-end sunscreen - from La Mer, with 30 spf, which was much thinner and absolutely invisible, but it was even higher priced and I was not psychologically prepared to buying it.
on 4/23/2010 8:37:00 PM
Age: 30-35
Skin: Acne-prone, Fair-Medium, Warm
Hair: Black, Wavy, Fine
Eyes: Brown
First, do not listen to reviews that say all you need are a few drops. You are not using sunscreen effectively then. You need to use at least a teaspoon (depending on which derm u speak with) on your face and reapply every couple of hours. Except 1 ounce equals 6 teaspoons. If u use the 1/4 teaspoon method, then there are only 24 applications in this bottle. Clearly this is super expensive and should not last u more than a month if u use it every day then. It works like other japanese fluid SS I have used but it appears to be way more expensive. I like shiseido more. But this is good too. But REALLY expensive.
on 4/23/2010 8:24:00 PM
Age: 36-43
Skin: Other, Other, Not Sure
Hair: Other, Other, Other
Eyes: Other
Great sunscreen. Protects very well.
on 4/20/2010 4:49:00 AM
Age: 19-24
Skin: Other, Fair-Medium, Not Sure
Hair: Black, Other, Other
Eyes: Brown
That first statement pretty much sums up my feeling for this sunscreen. $50+ for a tiny bottle might be extremely expensive for a sunscreen, but if you have the dough, do it. This will be the best sunscreen you will ever use. I use about a dime size to cover my entire face every morning after the rest of my skincare routine. It goes on extremely smoothly, and after a little bit, the slightly opaque layer will dry clear and matte. Its beautiful.
Btw, for all your products, including this one, I recommend you buy it at places with a great return policy such as any bigger department stores. If you don't like it, return it.
on 4/16/2010 5:09:00 AM
Age: 19-24
Skin: Combination, Fair, Neutral
Hair: Brunette, Wavy, Fine
Eyes: Green
I got a tester of this stuff in my search for the perfect daily sunscreen. I have an oily skin so I really want something that mattifies or at least doesn't make my skin more oily. This stuff did the trick. It didn't leave a white residue at all and it didn't make my face more oily. It worked great under make-up. Very good product.
I didn't end up buying this product though because of the steep competition (Clarins UV plus, Lancome DNA guard face fluid). I put this one on one side of my face and Clarins UV plus on the other side and left it like that all day. I saw no difference between the two in regards of white residue and shine, but the Clarins did hide my pores a bit better (only in the beginning of the day, later there was no difference) and it felt a bit lighter on the skin. The difference was absolutely minimal though and I don't think it would have mattered which one I bought, but I had to choose one. The lighter feeling of Clarins was the deciding factor for me, but Chanel has a higher SPF so it really depends on what you think is important. I think the Chanel and the Lancome (which I was using for years before and which I looove aswell) are also really similar. For now I chose the Clarins, but who knows I might try the Chanel next time (or go back to lancome). They're all great.
on 4/11/2010 6:21:00 PM
Age: 36-43
Skin: Normal, Fair, Cool
Hair: Brunette, Straight, Fine
Eyes: Brown
This is the newest incarnation of Chanel's facial sunblock, now in SPF 50 instead of SPF 30. UV Essentiel Multi-Protection Daily UV Care SPF 50 is a thin, milky white sunscreen with the active ingredients Octinoxate 7.5%, Titanium Dioxide 2% and Zinc Oxide 17.1%.
According to the Chanel website, "Skin's guardian angel provides invisible daily protection against environmental aggressors. A free-radical and anti-pollution shield with a Vitamin E derivative and plant extracts empowers this oil-free, lightweight formula to safeguard skin against environmental pollutants. Licorice Root Extract and a highly effective combination of UVA and UVB filters help diminish and prevent the appearance of dark spots and signs of premature aging."
According to the ingredients list, the licorice root extract is included in very small quantity, as are any other antioxidants, but at least the zinc oxide percentage is quite high. Even with the zinc oxide content, this sunscreen does not leave a white cast (at least on my fair skin) on dry down...even compared to the relatively clear Clarins UV Plus, and even when applied at the proper rate of 1/4 teaspoon for the face and 1/4 teaspoon for the neck. It does apply as a sheer white, but upon drying (which it does remarkably fast), it gives a soft matte finish and blurs imperfections. I have found that it can double as a makeup primer for my clear, normal/combo skin. It wears beautifully throughout the day without getting shiny. Makeup applies well over it without pilling. As with all Chanel products, there is a fragrance to it, so be aware if you are sensitive or averse. However, application is so pleasant and easy, and the finish is so lovely, I can overlook the fragrance. I have yet to find another facial sunscreen that is as cosmetically elegant as this one, and I've tried many, many, many products. The fact that it is primarily a physical block is also a plus in my book.
Of course, being Chanel, the price tag is obscene at $52 for 1 oz. I don't recommend skimping on the product, either. Although a very small amount will cover your face due to the thin and easily spreadable texture, you still need 1/4 teaspoon to get adequate sunscreen coverage or you are essentially just wasting product. Because of the cost, I will probably use it exclusively on my face and use one of my much less expensive sunscreens on my neck and chest. However, in my opinion, this one is well worth the cost for the ultimate payoff...a clear, smooth, matte finish that can double as a primer and offers superb, high-level protection. I feel this may very well be my HG sunscreen (finally!) and I plan to repurchase!
on 3/4/2010 4:10:00 AM
Age: 19-24
Skin: Combination, Fair-Medium, Not Sure
Hair: Brunette, Other, Other
Eyes: Brown
I decided to go in for this product after very high recommendations by one of the Chanel SAs. She told me that one bottle would go a long, long way, and trust me, it has. I was initially apprehensive because when you take a drop of this liquid on your finger, you can feel the oil content in it. But after application, it spreads very smoothly, and does not feel oily at all. I have an oily/combination skin, and this sunscreen has been working out extremely well.This has been my staple sunscreen under my foundation. I purchased this product around 6 months back, and I have still about half the bottle remaining.
Be sure to shake the bottle thoroughly before applying. It would also be advisable to apply mosturiser before applying this product, which then spreads like a dream. 3-4 drops is enough to cover the entire face and neck region. The only drawback would be its exorbitant price[ given the small size of the bottle], but considering how long it lasts, I'd say its worth it. I would definitely be repurchasing again.
on 10/25/2009 3:10:00 PM
Age: 19-24
Skin: Oily, Fair-Medium, Not Sure
Hair: Black, Other, Other
Eyes: Brown
This is probably the best sunscreen in the entire world for FOr ALL ETERNITY for people with combo/oily skin. It's in a really small bottle so you feel kinda guilty paying $50 dollars for it. But it does last a good while, and oohhh....is it worth it. You shake the bottle, and you only need a little bit like a dime size or less and it just smooths over your skin and it leaves a matte soft feeling. There's absolutely nooo stickiness, no gross oil slick shine. and the best thing of all....it doesn't break you out. LOVE LOVE LOVE LOVE it~ I'm on my second bottle
Popular Sunscreens


text:
Pileated gibbon
|Pileated gibbon[1]
|Male (dark) and female (pale)
|Conservation status
|Scientific classification
|H. pileatus
|Binomial name
|Hylobates pileatus
(Gray, 1861)
|Pileated gibbon range
The pileated gibbon (Hylobates pileatus) is a primate in the gibbon family, Hylobatidae.
The pileated gibbon has sexual dimorphism in fur coloration: males have a purely black fur, while the females have a white-grey colored fur with only the belly and head black. The white and often shaggy hair ring around the head is common to both sexes.
The range of the pileated gibbon is eastern Thailand, western Cambodia and southwest Laos. Its lifestyle is much like other gibbons: diurnal and arboreal, it lives together in a monogamous pair, brachiates through the trees with its long arms, and predominantly eats fruits, leaves and small animals. Reproduction habits are not well known, but are presumed to be similar to the other gibbons.
Audio gallery[edit]
Rescue, Rehabilitation and Release of the Pileated Gibbon[edit]
The non-profit organization Wildlife Alliance has cooperated with the Cambodian government to conduct rescue and release programs for the pileated gibbon in Cambodia:
- Rescue - A unique law enforcement team mandated to crack down on the illegal wildlife trade throughout Cambodia, the Wildlife Rapid Rescue Team confiscates approximately 5-6,000 live animals annually and has rescued more than 56,000 live animals from its creation in 2001 through 2013. Most of these animals are immediately released into safe habitat, and those who need temporary rehabilitation or permanent care are brought to Phnom Tamao Wildlife Rescue Centre. Gibbons are threatened by capture for the meat trade and pet trade in addition to threats by habitat loss. [3]
- Rehabilitation - Most of the pileated gibbons at Phnom Tamao Wildlife Rescue Centre were confiscated from the illegal meat trade or pet trade, rendering them too humanized to be released. However through the center's breeding program in which mothers raise their own offspring, gibbons have been successfully prepared for life in the wild. [4]
- Release - In December 2013 a pair of pileated gibbons were successfully released into the protected forests of the Angkor UNESCO World Heritage Site near the ancient temple complexes. This initiative by Wildlife Alliance, the Cambodian Forestry Administration and the Apsara Authority who manages the World Heritage site is the group's first step of many toward repopulating the formerly barren forests surrounding the famous Angkor temples. [5] [6] [7]
- ^ Groves, C. P. (2005). Wilson, D. E.; Reeder, D. M, eds. Mammal Species of the World (3rd ed.). Baltimore: Johns Hopkins University Press. p. 180. OCLC 62265494. ISBN 0-801-88221-4.
- ^ Brockelman, W., Geissmann, T., Timmins, T. & Traeholt, C. (2008). Hylobates pileatus. In: IUCN 2008. IUCN Red List of Threatened Species. Retrieved 4 January 2009.
- ^ http://www.wildlifealliance.org/page/view/82/wildlife/wildlife-rapid-rescue-team
- ^ http://wildlifealliance.org/page/view/436/endangered-gibbons-reintroduced-into-angkor-forest
- ^ http://wildlifealliance.org/page/view/436/endangered-gibbons-reintroduced-into-angkor-forest
- ^ http://www.prweb.com/releases/2013/12/prweb11434453.htm
- ^ http://vimeo.com/82294967
External links[edit]
|Wikispecies has information related to: Pileated gibbon
|This primate-related article is a stub. You can help Wikipedia by expanding it.


text:
JMPR Public Relations Signed on for Three Month Project With Kampgrounds of America, Inc.
KOA prides itself on bringing back the American Vacation with 450 beautiful and convenient Kampgrounds coast to coast that range from convenient full-service overnight facilities to larger resort-type campgrounds. KOA serves RV enthusiasts as well as tenters and many parks also rent small
KOA's three month agreement with JMPR will have focal points that include travel trends during cost conscious times and promoting family togetherness by expanding on the idea of bringing back the traditional American vacation.
JMPR (www.jmprpublicrelations.com) is based in
For more information on KOA, Kampgrounds of America, Inc., log on to www.koa.com or call (406) 248-7444 P.O Box 30558


text:
16.02.05 - By Don Caputo: To say that Bernard Hopkins, at forty years old, is in tremendous condition is a huge understatement to say the least; the undisputed middleweight king is a physical freak in the mould of the great late Archie Moore, the original ageless wonder who dominated the light heavyweight division well into his forties and beyond.
Hopkins as yet has shown zero signs of slowing down, if anything he is still gathering speed as he continues to dominate opposition and rule his division with an iron fist. His September knockout of Oscar De La Hoya was not only one of his finest performances to date, but it also made the statement that his speed, reflexes and power were all still firmly intact, seemingly booked in for the foreseeable future. The man eats, sleeps and breathes boxing, its as simple as that.
Hopkins' record breaking 19 title defenses is reflective of not only his extreme talent but also a remarkable dedication to the sport and an overall work ethic that has to be admired.
So how long can he realistically go on for? He is now officially an OAP in boxing years but in the wake of Roy Joness sudden and shocking demise he is currently regarded by most as the best fighter in the world pound for pound, the elite of the elite which in such a brutally demanding sport, physically and mentally, isnt too bad for an old man. Whats obvious though is that Bernard Hopkins is no ordinary man; he is one of the greats and like Sugar Ray Robinson, Muhammad Ali, Evander Holyfield and countless other ring legends before him he will be forever remembered and celebrated, but just like them though age will inevitably catch up to him, sooner or later. Obviously sooner wasnt the card Hopkins was dealt, but he really is at the point now where chinks in his armor are going to start appearing regardless of how well conditioned he is.
No one can stop the aging process, it is physiologically impossible, everybody gets old. At roughly the age of thirty our bodies begin to physically decline and it is a downward slope that cannot be reversed, at the end of the day all we can do is slow down the rate in which we age, something Hopkins has been able to achieve amazingly well. He is unquestionably past his physical prime though, which in a way has made every one of his fights over the past couple of years intriguing because of the possibility of him growing old over night, or at least showing some kind of vulnerability. It hasnt happened yet, but I guarantee you it will.
In his heyday Muhammad Ali was a defensive genius, his foot speed and razor sharp reflexes made him almost impossible to catch cleanly with any regularity. He famously did everything wrong in the ring, he was incredibly unorthodox but his extraordinary athleticism and natural ability allowed him to get away with the kind of fundamental mistakes that would certainly leave lesser fighters unconscious. When age and in his case inactivity began to dull these attributes he became a much easier target; his defense was totally dependant on the speed of his reflexes so when they left him he was a sitting duck and sadly ended up shipping far too much punishment. Because he was so gifted he never paid attention to the basics of boxing so he had nothing to fall back once his speed diminished.
Bernard Hopkins is a student of boxing and probably the most technically sound fighter in the world today, thats one of the reasons I believe he is still going so strong. Unlike Ali, and more recently Roy Jones, his style is not totally reliant on those first things you lose i.e. reflex speed; he effectively works from a rock solid foundation that has kept him at the top for over a decade. But, and this is a big but, he is not a machine, he will slow down eventually, and unless he calls it quits in the not too distant future he will grind to an abrupt halt. It would be a shame to see him tarnish his legacy because didnt know when to walk away.
I want to see Bernard Hopkins retire from the ring before the ring retires him, that would be truly sad to see. I know he still looks fantastic but its only a matter of time, age catches up to everyone in the end.
previous article: Bernard Hopkins: Still Something Left To Prove
next article: Zab Judah: The Top Dog at Welterweight?
If you detect any issues with the legality of this site, problems are always unintentional and will be corrected with notification.
The views and opinions of all writers expressed on Boxing247.com do not necessarily state or reflect those of the Management.
Copyright © 2001- 2015 Boxing247.com - Privacy Policy l Contact


text:
DSHS HIV/STD Program
Post Office Box 149347, MC 1873Austin, Texas 78714
Phone: (512) 533-3000
E-mail the HIV/STD Program
E-mail data requests to HIV/STD Program
DSHS strives to respond to all email requests in a timely manner. It is important to note, however, that messages that you send to us by email may not be secure and may be intercepted by a third party. Therefore, we recommend that you do not send any confidential health information to us by email.
To add a service provider or correct/update information for a currently listed provider, click here.
East Texas Community Health ServicesMailing: Post Office Box 632040 (75963)Physical: 1401 South University DriveNacogdoches, Texas 75961Tel: (936) 560-5413Fax: (936) 552-7240E-mail: firstname.lastname@example.com Served: Nacogdoches, Angelina, San Augustine, Shelby, Rusk, Cherokee, SabineArea of City: CentralClientele: Medically underservedSTD testing, primary care clinic, nurse on-site, physician on-site, TB testing, pregnancy testing, on-site laboratory diagnostics (limited), pharmacy/medication program, dental care, immunizations, family planning.
Health Horizons of East TexasMailing: Post Office Box 635022 (75963)Physical: 412 North Street, Suite FNacogdoches, Texas 75961Tel: (936) 569-8240Fax: (936) 569-2217E-mail: firstname.lastname@example.com: www.hhet.org [Health Horizons]Counties Served: Nacogdoches and 11 surrounding countiesArea of City: CentralClientele: General publicAnonymous HIV testing (free), confidential HIV testing (free), prevention counseling, individual ongoing counseling, peer counseling, health education/risk reduction, HIV prevention education, street outreach, educational materials, HIV/AIDS clinical treatment, nurse on-site, dental care for HIV-positive, case management for HIV/AIDS, financial education/emergency assistance, food pantry, housing assistance, legal services (HIV), medication assistance program, nutrition services, support groups, transportation, volunteer services, insurance assistance, optical services. Spanish speaking staff available.
Hospice of Deep East Texas907 MoundNacogdoches, Texas 75961Tel: (936) 560-9277Fax: (936) 560-9606E-mail: email@example.com Served: Nacogdoches, Angelina, Cherokee, Houston, Panola, Rusk, Sabine, San Augustine, ShelbyArea of City: EastClientele: Terminally illHome visits/home health care, hospice.
Lone Star Legal Aid414 East Pillar StreetNacogdoches, Texas 75961Tel: (936) 560-1455Toll-free: (800) 354-1889Fax: (936) 560-5385Web: www.lonestarlegal.org [Lone Star Legal Aid]Counties Served: Nacogdoches, Anderson, Angelina, Cherokee, Houston, Jasper, Nacogdoches, Newton, Sabine, San Augustine, Shelby, TylerClientele: General publicLegal representation and legal advice for clients who meet the poverty guidelines.
Abstinence Resource CouncilPhysical: 652 Loop 337Mailing: Post Office Box 310220New Braunfels, Texas 78130Tel: (830) 643-4162Fax: (830) 629-4967E-mail: firstname.lastname@example.com: http://worththewait.org/ [ARC]Counties Served: ComalClientele: 6th grade through high school-aged students, parents, teachers, adults, and health care professionalsHealth education/risk reduction, HIV prevention education, STD prevention education, hepatitis prevention education, peer education, educational materials, documented, medically accurate information presented in reference to prevention. Books, brochures, and DVD/videos are available for free or to check out.
Comal County Health Department178 East Mill Street, Suite 210New Braunfels, Texas 78130Tel: (830) 608-2015Fax: (830) 620-3495Web: www.co.comal.tx.us [Comal County] Counties Served: Comal, Guadalupe, Bexar, Hays, BlancoArea of City: CentralClientele: General publicConfidential HIV testing, STD testing and treatment, hepatitis testing, TB testing, prevention counseling, HIV prevention education, STD prevention education, hepatitis prevention education, educational materials, nurse on-site, hepatitis vaccination. Spanish speaking staff available. One day each week a Nurse Practitioner provides wellness/annual exams, family planning, school physicals, routine lab and STD testing/treatment for a fee for service. Other health department services include blood pressure monitoring, pregnancy testing & child/adult immunizations.
ConnectionsMailing: Post Office Box 311268 (78131)Physical: 1414 West San Antonio StreetNew Braunfels, Texas 78130Tel: (830) 629-6571Fax: (830) 629-8147E-mail: email@example.com or firstname.lastname@example.com: www.connectionsnonprofit.org [Connections]Counties served: Central and southeast Texas.Area of City: SouthwestClientele: General publicPrevention counseling, individual ongoing counseling, HIV prevention education, STD prevention education, substance abuse intervention, support groups, hotline/telephone counseling, brochures, posters.
Basin Assistance Services (BAS)1330 East 8th Street, Suite 410Odessa, Texas 79763Tel: (432) 580-0713Toll Free: (800) 804-5418Fax: (432) 580-0972Counties Served: Andrews, Borden, Crane, Dawson, Ector, Gaines, Glasscock, Howard, Loving, Martin, Midland, Pecos, Reeves, Terrell, Upton, Ward, WinklerArea of City: WestClientele: HIV/AIDS clientsAnonymous HIV testing, confidential HIV testing, HIV early intervention, case management for HIV/AIDS, clinical treatment for HIV/AIDS, nurse on-site, TB testing, prescription assistance, support groups, food pantry, transportation, housing assistance, brochures.
Ector County Health Department221 North Texas AvenueOdessa, Texas 79761-5175Tel: (432) 498-4141Fax: (432) 498-4143E-mail: firstname.lastname@example.com Served: Permian BasinArea of City: CentralClientele: General publicAnonymous HIV testing, confidential HIV testing, STD testing, prevention counseling, health education/risk reduction, HIV prevention education, STD prevention education, nurse on-site, hepatitis education, Hepatitis A vaccine-children, Hepatitis B vaccine-adults, Hepatitis B vaccine-children, TB testing, TB treatment, on-site laboratory diagnostics (limited), pharmacy/medication program, immunizations.
Planned Parenthood of West Texas910-B South GrantOdessa, Texas 79761Tel: (432) 580-9855Fax: (432) 580-8551E-mail: firstname.lastname@example.com Served: Ector and 50 West Texas countiesArea of City: SouthClientele: General publicSTD testing and treatment, prevention counseling, health education/risk reduction, HIV prevention education, STD prevention education, educational materials, nurse on-site, volunteer services. Spanish Speaking staff available.
Orange County Health Department - UTMB Clinic2014 North 10th StreetOrange, Texas 77630Tel: (409) 883-6119Fax: (409) 883-3147E-mail: firstname.lastname@example.com Served: Orange, Jefferson, and surrounding countiesClientele: General publicAnonymous HIV testing (free), confidential HIV testing, STD testing, prevention counseling, health education/risk reduction, HIV prevention education, STD prevention education, outpatient services, nurse on-site, hepatitis testing, hepatitis education/counseling, Hepatitis A vaccine-children (free-$10), Hepatitis B vaccine-children (free-$10), TB testing, TB treatment, pregnancy testing, immunizations, support groups, nutrition services, WIC, family planning.
Southeast Texas Hospice912 West CherryOrange, Texas 77631Tel: (409) 886-0622Fax: (409) 886-0623E-mail: email@example.com: www.setxhospice.com [Southeast Texas Hospice]Counties Served: Orange and JeffersonClientele: Terminally illHospice, volunteer services.
Internet Policy | HHS Agencies | Homeland Security | Statewide Search | Texas.gov | Privacy Practices


text:
Heat waves, droughts, wildfires, and other extreme weather events -- some of the most troubling, costly, and immediate impacts of climate change -- pose very real threats to our public health, infrastructure, and economy.
Read Whole Story
Power plants are the single largest source of carbon pollution in the United States, producing nearly one-third of all domestic greenhouse gas emissions. And yet, there are no limits on what they can emit into the atmosphere. That is what makes this announcement so notable.
Surely you have heard that the Republican-controlled House of Representatives has voted to reinstate the Global Gag Rule that prevents any family planning agencies that provide information about abortion service from receiving any U.S. foreign aid.
On Saturday morning, a group of House Republicans -- led by Rep. Tom Price (R-Georgia) -- attempted to stop the Democratic Women's Caucus from making ...
The Stupak-Pitts amendment that replaced my amendment goes well beyond the status quo. It would result in a major step backwards for women's control over their reproductive lives.
My amendment offers a common ground solution to a very challenging policy question -- namely how do we deal with abortion services in health reform legislation.
Reflecting recent seesawing in the race for the Democratic nomination, which seemed all but won by Obama two weeks ago, Party superdelegates, far from tipping the race, are still divided.
Get top stories and blog posts emailed to me each day..